A
Alzamend Neuro, Inc. (ALZN)
NCM – Real vaqt narxi. Valyuta: USD
1.02
-0.03 (-2.86%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Aksiya tahlili uchun eng kuchli vositalarga ega bo'ling
Find any stock by ticker or company name
NCM – Real vaqt narxi. Valyuta: USD
1.02
-0.03 (-2.86%)
Yopilishda: May 12, 2026, 4:00 PM EDT
Alzamend Neuro, Inc., klinik bosqichdagi biofarmatsevtika kompaniyasi, neyrodegenerativ va ruhiy kasalliklarni davolash uchun turli mahsulotlarni ishlab chiqishga qaratilgan. Uning dasturi quyidagilarni o'z ichiga oladi: Alzheimer kasalligi, bipolyar buzuqlik, post-travmatik stress buzilishi, katta depressiv buzuqlik, boshqa neyrodegenerativ kasalliklar va ruhiy kasalliklarni davolash uchun litiy, prolin va salitsilatning terapevtik kombinatsiyasini etkazib beradigan AL001; va ALZN002, bu bemorning immun tizimining Alzheimer kasalligiga qarshi kurashish qobiliyatini tiklash uchun hujayra asosidagi terapevtik vaksina sifatida mutatsiyaga uchragan peptidni sezgir hujayradan foydalanish usulini qo'llaydi. Alzamend Neuro, Inc. 2016 yilda ro'yxatga olingan va shtab-kvartirasi Jorjiya shtatining Atlanta shahrida joylashgan.
| Ism | Lavozim |
|---|---|
| Mr. David J. Katzoff | Chief Financial Officer |
| Mr. Henry C. W. Nisser Esq. | Executive VP, General Counsel & Director |
| Mr. Kenneth S. Cragun CPA | Senior Vice President of Finance |
| Mr. Milton Charles Ault III | Founder & Vice Chairman |
| Mr. Stephan Jackman | CEO & Director |
| Sana | Turi | Hujjat |
|---|---|---|
| 2026-04-17 | 8-K | p4172668k.htm |
| 2026-03-20 | 8-K | g3202628k.htm |
| 2026-03-11 | 10-Q | z3626110q.htm |
| 2026-03-06 | 8-K | d362618k.htm |
| 2026-02-26 | DEF 14A | i225262def14a.htm |
| 2026-02-09 | PRE 14A | g29260pre14a.htm |
| 2025-12-09 | 10-Q | r12325010q.htm |
| 2025-11-18 | 8-K | x11172508k.htm |
| 2025-10-14 | 8-K | b10142528k.htm |
| 2025-10-09 | 8-K | o1082528k.htm |